• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳基丙基磺酰胺类化合物的细胞毒性活性及定量构效关系。

Cytotoxic activity and quantitative structure activity relationships of arylpropyl sulfonamides.

机构信息

College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea.

出版信息

Korean J Physiol Pharmacol. 2013 Jun;17(3):237-43. doi: 10.4196/kjpp.2013.17.3.237. Epub 2013 Jun 11.

DOI:10.4196/kjpp.2013.17.3.237
PMID:23776401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3682085/
Abstract

B13 is a ceramide analogue and apoptosis inducer with potent cytotoxic activity. A series of arylpropyl sulfonamide analogues of B13 were evaluated for their cytotoxicity using MTT assays in prostate cancer PC-3 and leukemia HL-60 cell lines. Some compounds (4, 9, 13, 14, 15, and 20) showed stronger activities than B13 in both tumor cell lines, and compound (15) gave the most potent activity with IC50 values of 29.2 and 20.7 µM, for PC-3and HL-60 cells, respectively. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis was performed to build highly reliable and predictive CoMSIA models with cross-validated q(2) values of 0.816 and 0.702, respectively. Our results suggest that long alkyl chains and a 1R, 2R configuration of the propyl group are important for the cytotoxic activities of arylpropyl sulfonamides. Moreover, the introduction of small hydrophobic groups in the phenyl ring and sulfonamide group could increase biological activity.

摘要

B13 是一种神经酰胺类似物和凋亡诱导剂,具有很强的细胞毒性。我们评价了一系列 B13 的芳基丙基磺酰胺类似物对前列腺癌 PC-3 和白血病 HL-60 细胞系的细胞毒性,采用 MTT 法进行检测。在这两种肿瘤细胞系中,一些化合物(4、9、13、14、15 和 20)的活性均强于 B13,化合物 15 的活性最强,对 PC-3 和 HL-60 细胞的 IC50 值分别为 29.2 和 20.7 μM。我们进行了三维定量构效关系(3D-QSAR)分析,构建了高度可靠和可预测的 CoMSIA 模型,交叉验证 q(2) 值分别为 0.816 和 0.702。结果表明,芳基丙基磺酰胺的长烷基链和丙基 1R,2R 构型对其细胞毒性活性很重要。此外,苯环和磺酰胺基上引入小的疏水性基团可以提高生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/7c3de1d1064e/kjpp-17-237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/4aec89e6537e/kjpp-17-237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/958a3f6e529e/kjpp-17-237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/7c3de1d1064e/kjpp-17-237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/4aec89e6537e/kjpp-17-237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/958a3f6e529e/kjpp-17-237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6650/3682085/7c3de1d1064e/kjpp-17-237-g003.jpg

相似文献

1
Cytotoxic activity and quantitative structure activity relationships of arylpropyl sulfonamides.芳基丙基磺酰胺类化合物的细胞毒性活性及定量构效关系。
Korean J Physiol Pharmacol. 2013 Jun;17(3):237-43. doi: 10.4196/kjpp.2013.17.3.237. Epub 2013 Jun 11.
2
Cytotoxic Activity and Structure Activity Relationship of Ceramide Analogues in Caki-2 and HL-60 Cells.神经酰胺类似物对 Caki-2 和 HL-60 细胞的细胞毒性及构效关系。
Korean J Physiol Pharmacol. 2010 Dec;14(6):441-7. doi: 10.4196/kjpp.2010.14.6.441. Epub 2010 Dec 31.
3
Cytotoxicities and Quantitative Structure Activity Relationships of B13 Sulfonamides in HT-29 and A549 Cells.B13 磺胺类化合物对 HT-29 和 A549 细胞的细胞毒性及定量构效关系。
Korean J Physiol Pharmacol. 2011 Dec;15(6):423-9. doi: 10.4196/kjpp.2011.15.6.423. Epub 2011 Dec 27.
4
Cytotoxicity and Structure-activity Relationships of Naphthyridine Derivatives in Human Cervical Cancer, Leukemia, and Prostate Cancer.萘啶衍生物在人宫颈癌、白血病和前列腺癌中的细胞毒性及构效关系。
Korean J Physiol Pharmacol. 2013 Dec;17(6):517-23. doi: 10.4196/kjpp.2013.17.6.517. Epub 2013 Dec 16.
5
Synthesis and cytotoxicity of new aromatic ceramide analogs with alkylsulfonamido chains.含烷基磺酰胺链的新型芳香族神经酰胺类似物的合成与细胞毒性
Arch Pharm Res. 2007 May;30(5):570-80. doi: 10.1007/BF02977651.
6
Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.2-芳基-1,8-萘啶-4(1H)-酮的细胞毒性活性和三维定量构效关系。
Korean J Physiol Pharmacol. 2009 Dec;13(6):511-6. doi: 10.4196/kjpp.2009.13.6.511. Epub 2009 Dec 31.
7
Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts.森田-贝利斯-希尔曼加合物的合成、对白血病细胞系的细胞毒性活性及定量构效关系(QSAR)研究
Med Chem. 2016;12(7):602-612. doi: 10.2174/1573406412666160506150924.
8
3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.苯磺酰胺类似物作为碳酸酐酶 II 抑制剂的 3D-QSAR 研究。
Bioorg Med Chem Lett. 2010 May 15;20(10):3089-93. doi: 10.1016/j.bmcl.2010.03.104.
9
New p-methylsulfonamido phenylethylamine analogues as class III antiarrhythmic agents: design, synthesis, biological assay, and 3D-QSAR analysis.新型对甲基磺酰胺基苯乙胺类似物作为Ⅲ类抗心律失常药物:设计、合成、生物学测定及三维定量构效关系分析
J Med Chem. 2002 Jul 4;45(14):2953-69. doi: 10.1021/jm010574u.
10
3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.人碳酸酐酶II磺酰胺抑制剂的3D-QSAR研究
Eur J Med Chem. 2007 Mar;42(3):365-72. doi: 10.1016/j.ejmech.2006.09.022. Epub 2006 Nov 21.

引用本文的文献

1
Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression.芪参益气滴丸通过调控MicroRNA-223-3p表达促进缺血心肌微血管内皮细胞血管生成
Evid Based Complement Alternat Med. 2016;2016:5057328. doi: 10.1155/2016/5057328. Epub 2016 Feb 15.
2
MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway.微小RNA-223-3p通过影响RPS6KB1/hif-1a信号通路抑制缺血性心脏微血管内皮细胞的血管生成。
PLoS One. 2014 Oct 14;9(10):e108468. doi: 10.1371/journal.pone.0108468. eCollection 2014.
3

本文引用的文献

1
Cytotoxic Activity and Structure Activity Relationship of Ceramide Analogues in Caki-2 and HL-60 Cells.神经酰胺类似物对 Caki-2 和 HL-60 细胞的细胞毒性及构效关系。
Korean J Physiol Pharmacol. 2010 Dec;14(6):441-7. doi: 10.4196/kjpp.2010.14.6.441. Epub 2010 Dec 31.
2
Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.鞘氨醇、神经氨醇和 C(2)-神经酰胺诱导人结肠癌细胞凋亡,但 C(2)-二氢神经酰胺则否。
Anticancer Res. 2010 Jul;30(7):2881-4.
3
Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Cytotoxicity and Structure-activity Relationships of Naphthyridine Derivatives in Human Cervical Cancer, Leukemia, and Prostate Cancer.
萘啶衍生物在人宫颈癌、白血病和前列腺癌中的细胞毒性及构效关系。
Korean J Physiol Pharmacol. 2013 Dec;17(6):517-23. doi: 10.4196/kjpp.2013.17.6.517. Epub 2013 Dec 16.
柚皮苷可预防鱼藤酮诱导的人神经母细胞瘤 SH-SY5Y 细胞凋亡。
Korean J Physiol Pharmacol. 2009 Aug;13(4):281-5. doi: 10.4196/kjpp.2009.13.4.281. Epub 2009 Aug 31.
4
Ceramide-induced cell death in malignant cells.神经酰胺诱导恶性细胞死亡。
Cancer Lett. 2008 Jun 8;264(1):1-10. doi: 10.1016/j.canlet.2008.02.020. Epub 2008 Mar 18.
5
Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents.新型D-e-MAPP和B13类似物。第1部分:作为潜在抗癌剂的合成与评价。
Bioorg Med Chem. 2008 Jan 15;16(2):1015-31. doi: 10.1016/j.bmc.2007.08.033. Epub 2007 Aug 24.
6
Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells.溶酶体促渗酸性神经酰胺酶抑制剂诱导前列腺癌细胞凋亡。
Cancer Chemother Pharmacol. 2008 Feb;61(2):231-42. doi: 10.1007/s00280-007-0465-0. Epub 2007 Apr 12.
7
Induction of apoptotic cell death by a ceramide analog in PC-3 prostate cancer cells.一种神经酰胺类似物诱导PC-3前列腺癌细胞发生凋亡性细胞死亡。
Arch Pharm Res. 2006 Dec;29(12):1140-6.
8
Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues.2-氧代辛酰基和N-油酰乙醇胺类似物作为酸性神经酰胺酶抑制剂的设计、合成及活性
Chem Phys Lipids. 2006 Oct;144(1):69-84. doi: 10.1016/j.chemphyslip.2006.07.001. Epub 2006 Aug 7.
9
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.药理学抑制或靶向酸性神经酰胺酶的小干扰RNA使肝癌细胞对化疗敏感,并在体内减少肿瘤生长。
Oncogene. 2007 Feb 8;26(6):905-16. doi: 10.1038/sj.onc.1209834. Epub 2006 Jul 24.
10
Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells.阳离子长链神经酰胺LCL-30通过靶向线粒体诱导SW403细胞死亡。
Mol Cancer Ther. 2006 Jun;5(6):1520-9. doi: 10.1158/1535-7163.MCT-05-0513.